Global Artificial Intelligence (AI) In Medical Writing Industry Outlook 2025-2029: Market Set to Cross $1.78 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Artificial Intelligence (AI) In Medical Writing Industry Market Size Be by 2025?
The market size for artificial intelligence (AI) in medical writing has seen substantial expansion in recent years. The market is predicted to inflate from $0.91 billion in 2024 to $1.05 billion in 2025, boasting a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historic period include an increase in contract research organization outsourcing, escalating medical writing costs, trade deals and governmental policies, increased complication in the regulatory approval process, and a surging demand for precise and dependable medical content.

What's the Long-Term Growth Forecast for the Artificial Intelligence (AI) In Medical Writing Market Size Through 2029?
The market for artificial intelligence (AI) in medical writing is projected to experience a significant increase over the forthcoming years, reaching a valuation of $1.78 billion by 2029, with a compounded annual growth rate (CAGR) of 14.2%. The anticipated progress during this forecast period is attributed to a promising climate for clinical research, the extensive adoption of telehealth and distance-based healthcare services, the development of digital infrastructure, heightened public understanding of the benefits AI offers in healthcare, and the mounting demand for precise and trustworthy medical information. Key trends forecasted for this period encompass progress in natural language processing (NLP) and machine learning algorithms, the utilization of machine learning (ML), the surge of digital health services, collaboration with next-generation technologies, and advancements in clinical decision support systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-medical-writing-global-market-report

What Are the Key Growth Drivers Fueling the Artificial Intelligence (AI) In Medical Writing Market Expansion?
The surge in demand for innovative pharmaceutical drugs and treatments is set to fuel the expansion of artificial intelligence (AI) in the domain of medical writing. This escalating need for new medicines and therapies stems from the ongoing requirement to fulfil unaddressed medical necessities, counteract drug resistance, manage evolving ailments, and enhance patient outcomes via ingenious and more efficient remedies. Employing AI in medical writing, specifically within the sectors of pharmaceutical production, augments accuracy, innovation, and efficiency, thereby aiding in creating safer and more robust treatments for a myriad of health conditions. As an illustration, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA) in June 2023 indicated that Europe's total pharmaceutical production accounted for $384,200 million (€340,000 million) in 2022, marking an approximate increase of 4.95% from 366,267 million (€323,950 million) in 2021. Consequently, the rising requirement for novel pharmaceutical drugs and therapies is likely to spur the growth of artificial intelligence (AI) in the medical writing landscape.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16590&type=smp

What Are the Key Trends Driving Artificial Intelligence (AI) In Medical Writing Market Growth?
Leading companies in the AI medical writing market are concentrating on incorporating advanced features such as AI-powered drafting to improve efficiency and precision in document creation and management for regulatory submissions and medical communications. AI-powered drafting deploys artificial intelligence algorithms to automatically create preliminary drafts or outlines of documents, utilizing machine learning and natural language processing to aid in content creation tasks. For instance, in June 2024, US-based pharmaceutical technology company TrialAssure launched TrialAssure LINK AI 2.0. This improved version allows pharmaceutical and biotechnology companies, clinical research organizations, and service providers to effectively produce regulatory and medical writing documents using AI. The solution streamlines the creation of various clinical and technical documents, from the initial drafting to the final approval stages, making the entire authoring process more efficient.

How Is the Artificial Intelligence (AI) In Medical Writing Market Segmented?
The artificial intelligence (ai) in medical writingmarket covered in this report is segmented -

1) By Type: Clinical Writing, Type Writing, Scientific Writing, Other Types
2) By Application: Regulatory Documentation, Automated Literature Review, Language Translation, Pharmacovigilance, Content Modularization
3) By End Use: Medical Devices, Pharmaceutical, Biotechnology, Other End Users

Subsegments:
1) By Clinical Writing: Clinical Trial Documentation, Regulatory Submission Documents, Patient Narratives, Protocol Writing, Investigator Brochures
2) By Type Writing: Automated Transcription Services, AI-Based Text Generation For Medical Content, Document Formatting And Proofreading
3) By Scientific Writing: Research Papers, Literature Reviews, Manuscripts For Peer-Reviewed Journals, Grant Proposal Writing
4) By Other Types: Medical Marketing Content, Educational Materials (Patient Brochures, Guides), Healthcare Website Content, Medical Content For AI-Driven Chatbots Or Virtual Assistants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16590&type=smp

Which Companies Are Leading the Charge in Artificial Intelligence (AI) In Medical Writing Market Innovation?
Major companies operating in the artificial intelligence (AI) in medical writing market are International Business Machines Corporation, IQVIA Holdings Inc., Icon PLC, Syneos Health Pvt Ltd, Parexel International Corporation, Veeva Systems, Cactus Communications, Tata Elxsi, Allucent Inc, Certara Inc, Freyr Solutions, Amplity Health, Indegen Limited, MMS Holdings Inc., Jasper AI Inc, Symbiance AI Inc, GenInvo Technologies Pvt. Ltd., Trilogy Writing & Consulting GmbH, Yseop S.A.S., Turacoz Healthcare Solution, Averbis GmbH, EMTEX Life Sciences, DeepCura AI, Dezzai Inc, Narrativa Inc

Which Regions Are Leading the Global Artificial Intelligence (AI) In Medical Writing Market in Revenue?
North America was the largest region in the artificial intelligence (AI) in medical writing market in 2024. The regions covered in the artificial intelligence (AI) in medical writing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16590

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.